Adenosine vs calcium channel blockers
Major adverse event: hypotension · patients with supraventricular tachycardia
1 finding from 1 review
- Adenosine versus intravenous calcium channel antagonists for supraventricular tachycardia 2017 · Cochrane Headline outcomes onlyno estimate extracted306 participantsLow